📋 Testosterone Panel (Pre-TRT)

What this panel can settle, and by what logic

This panel settles one thing well and it is not “do I have low testosterone”. It settles what your numbers were before you changed them, and that is a question with an expiry date: after the first injection it can never be answered again.

Three of the 80-odd markers do that work.

1. Hematocrit, on the Complete Blood Count (CBC) with Differential. Testosterone raises red cell mass, and the rate is not small. In a cohort of trans men on testosterone, erythrocytosis reached a hematocrit above 0.50 L/L in 11%, above 0.52 L/L in 3.7%, and above 0.54 L/L in 0.5% Madsen 2021. A pre-treatment hematocrit of 0.49 L/L and one of 0.42 L/L are the same therapy with completely different headroom, and only one of them has 2 years of running room.
2. PSA (Total + Free + % Free). A rise from 0.8 to 1.9 ng/mL over 24 months is a different clinical object from a man who has always sat at 1.9 ng/mL, and monitoring guidance is written around the change, not the level Basheer 2025.
3. LH & FSH with Total Testosterone. Low testosterone with high LH is testicular; low testosterone with low or normal LH is pituitary or hypothalamic, and the two have different causes and different treatments Livingston 2023. Once exogenous testosterone suppresses LH this discrimination is gone permanently.

The panel also gives you a real Estradiol, Sensitive (LC/MS-MS) and SHBG (Sex Hormone-Binding Globulin) baseline, which is what makes the testosterone-to-estradiol ratio interpretable later rather than a number people argue about Swislocki 2024.

What it cannot settle, and what would

It cannot diagnose hypogonadism on its own, because one morning draw is not a diagnosis. Testosterone has substantial within-subject biological variation and a single low value reclassifies on a repeat in a meaningful share of men Itkonen 2024; the laboratory position is two morning samples on separate days before anyone treats Livingston 2023. This is one product bought once, so the second draw is a second purchase and it should be planned, not discovered.

It cannot tell you whether your fertility will come back. Exogenous testosterone suppresses the gonadotropins and with them spermatogenesis, and recovery time after stopping varies from months to years with no reliable pre-treatment predictor Desai 2022. If children are anywhere in the plan, the test that answers this is a semen analysis and a sperm bank, before the first injection.

It cannot exclude prostate cancer. A PSA (Total + Free + % Free) of 1.1 ng/mL is a baseline, not an all-clear, and the reason it is on the list is comparison over 5 to 10 years rather than reassurance today Basheer 2025.

And it cannot decide whether you should start. That is a symptom-plus-number decision made with a prescriber. A panel that arrives 2 weeks before the conversation makes the conversation better; it does not replace it.

Draw conditions that decide whether the money is wasted

The draw conditions here matter more than on any other panel on this site, for a reason specific to a baseline: every future result gets compared to this one, so a badly drawn baseline poisons 10 years of monitoring rather than one morning.

1. 7 to 10am, fasted. Testosterone follows a diurnal rhythm and an afternoon draw reads lower, so a baseline drawn at 3pm makes every morning value afterward look like a response to therapy Livingston 2023.
2. Write down the laboratory and the method. Immunoassay and LC-MS/MS do not return the same Total Testosterone, and the same applies to Estradiol, Sensitive (LC/MS-MS), where the sensitive assay is the only one worth having in men Swislocki 2024.
3. Not within 48 hours of hard training or 2 weeks of an illness, both of which move the axis and the Complete Blood Count (CBC) with Differential at once.
4. No biotin for 72 hours Li 2020, and no hCG, clomiphene or anastrozole in the preceding 6 weeks — all three change the exact numbers this panel exists to fix in place.

How you would know it answered your question, and what each pattern means next

What to do with a baseline is mostly what to do later, so these are the comparisons this draw is buying.

• Baseline hematocrit above 0.48 L/L: you are starting with little headroom, and 11% of testosterone users cross 0.50 L/L Madsen 2021. Recheck the Complete Blood Count (CBC) with Differential at 3 months and 6 months rather than annually.
• Total Testosterone under 300 ng/dL: repeat it on a separate morning before anything else happens Itkonen 2024. Two low morning values is the finding; one is a number.
• Low testosterone with a normal or low LH & FSH: secondary. Add Prolactin and ferritin before accepting TRT as the answer, because a prolactinoma and hemochromatosis both present this way and both are treated differently Livingston 2023.
• PSA (Total + Free + % Free) above 4 ng/mL, or above 2.5 ng/mL under 50: this gets assessed before the first injection, not after Basheer 2025.
• ApoB (Apolipoprotein B) and Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) at baseline: testosterone moves HDL, so the only way to know whether your lipids changed is to have measured them first Basheer 2025.

Sources read for these sections

• Livingston M, et al. Adult Male Hypogonadism: A Laboratory Medicine Perspective on Its Diagnosis and Management. Diagnostics (Basel) 2023 · PMID 38132234
• Itkonen O, et al. The European biological variation study (EuBIVAS): Biological variation data for testosterone, follicle stimulating hormone, prolactin, luteinizing hormone and dehydroepiandrosterone sulfate in men. Clinica Chimica Acta 2024 · PMID 38341016
• Madsen MC, et al. Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-Term Follow-Up Study on Prevalence, Determinants, and Exposure Years. Journal of Clinical Endocrinology and Metabolism 2021 · PMID 33599731
• Basheer B, et al. Management of Adverse Effects in Testosterone Replacement Therapy. International Braz J Urol 2025 · PMID 39908204
• Desai A, et al. Understanding and managing the suppression of spermatogenesis caused by testosterone replacement therapy (TRT) and anabolic-androgenic steroids (AAS). Therapeutic Advances in Urology 2022 · PMID 35783920
• Swislocki ALM, et al. A Review on Testosterone: Estradiol Ratio-Does It Matter, How Do You Measure It, and Can You Optimize It?. World Journal of Men's Health 2024 · PMID 39344113
• Li D, Ferguson A, Cervinski MA, Lynch KL, Kyle PB. AACC Guidance Document on Biotin Interference in Laboratory Tests. J Appl Lab Med 2020 · PMID 32445355